HF774 (Legislative Session 94 (2025-2026))
Coverage of vasectomies required by health plans.
Related bill: SF1054
AI Generated Summary
Purpose
- The bill aims to require health plans to cover vasectomies (male sterilization) and to adjust definitions related to contraceptive services and related terms. It seeks to ensure that vasectomy services are covered by health plans and not misclassified under other contraceptive service terms.
Main Provisions
- Amends Minnesota Statutes 2024 section 62Q.522 subdivision 1 to redefine key terms:
- Contraceptive method: a drug, device, or other product FDA-approved to prevent unintended pregnancy.
- Contraceptive service: includes consultations, examinations, procedures, and medical services related to preventing unintended pregnancy; also includes patient education, counseling, follow-up, device insertion or removal; explicitly excludes vasectomies.
- Medical necessity: includes factors such as severity of side effects, the permanence or reversibility of a method, and the patient’s ability to adhere to proper use, as determined by the attending provider.
- Therapeutic equivalent version: a drug, device, or product that has the same clinical effect and safety profile when used as labeled, and meets defined standards for equivalence and labeling.
- Pharmaceutical equivalents, bioequivalence, proper labeling, and current manufacturing practice standards are defined to establish when products can be substituted or deemed equivalent.
- Central policy change: requires health plans to cover vasectomies, adding coverage for this sterilization procedure and clarifying that vasectomies are not part of the defined “contraceptive service” category.
Significance and What It Changes
- Clarifies that vasectomies are not included in the contraceptive service category, which helps ensure vasectomy coverage is addressed separately under health plan benefits.
- Establishes explicit definitions related to contraception, medical necessity, and product equivalence to guide coverage decisions and ensure standardization across medications and devices used in related services.
- Sets expectations for coverage decisions by tying medical necessity to provider judgment and patient-specific factors, potentially affecting cost-sharing and access.
Definitions Highlight (Key Terms from the Bill)
- Vasectomy
- Health plans
- Contraceptive method
- Contraceptive service
- Medical necessity
- Therapeutic equivalent version
- Pharmaceutical equivalents
- Bioequivalence
- FDA (Food and Drug Administration)
- Current manufacturing practice
Relevant Terms
vasectomy, health plans, contraceptive method, contraceptive service, medical necessity, therapeutic equivalent version, pharmaceutical equivalents, bioequivalence, FDA, current manufacturing practice
Actions
| Date | Chamber | Where | Type | Name | Committee Name |
|---|---|---|---|---|---|
| February 13, 2025 | House | Action | Introduction and first reading, referred to | Commerce Finance and Policy | |
| February 19, 2025 | House | Action | Author added | ||
| March 12, 2025 | House | Action | Author added |
Citations
[
{
"analysis": {
"added": [
"Adds definitions for 'Contraceptive method' and 'Contraceptive service', including that contraceptive service excludes vasectomies.",
"Adds definition of 'Medical necessity' with considerations such as severity of side effects, difference in permanence and reversibility, and the ability to adhere to appropriate use.",
"Adds definition of 'Therapeutic equivalent version' and its criteria (drug/device/product with the same clinical effect and safety profile under labeling conditions).",
"Incorporates criteria related to bioequivalence, labeling, and manufacturing standards for therapeutic equivalents."
],
"removed": [],
"summary": "This bill amends Minnesota Statutes 2024 section 62Q.522 subdivision 1 to redefine definitions related to contraceptive methods and services, and to establish criteria for therapeutic equivalence and related standards.",
"modified": [
"Amends Subdivision 1 definitions to incorporate these new terms and clarifications, affecting how contraceptive methods and services are defined and evaluated for coverage purposes."
]
},
"citation": "62Q.522",
"subdivision": "Subdivision 1"
}
]Progress through the legislative process
In Committee